This medical webinar was funded and supported by Amryt Pharma. The content of this webinar is intended for healthcare professionals who work in the dermatology field.
This dermatology webinar reviewed the key findings and outcomes from the largest phase 3 study to be conducted in epidermolysis bullosa (EB), the EASE study. This study evaluated the efficacy and safety of birch bark extract, also known as Oleogel-S10, for the treatment of partial thickness wounds in dystrophic and junctional EB.
The webinar includes presentations and discussions from two leading global experts in EB who were also EASE investigators: Professor Dedee Murrell (Head at the Department of Dermatology, St. George Hospital, University of New South Wales, Sydney, Australia) and Professor Dimitra Kiritsi (Consultant Dermatologist and Group Leader at the Department of Dermatology, Albert Ludwig University of Freiburg, Freiburg im Breisgau, Germany). They are joined by our expert moderator, Sue Saville.
This webinar spotlighted:
- An overview of EB
- A summary of the EASE study design, aims, key endpoints, safety and long-term data
- The implications of the findings from EASE for clinical practice, patients, and care givers
